Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney disease
Viji Remadevi, Abeda Jamadar, Meekha M. Varghese, Haichun Yang, Sumedha Gunewardena, Darren P. Wallace, Reena Rao
This study shows pirfenidone reduces fibrosis and improves kidney function in ADPKD by targeting myofibroblast activation and ECM production.
JCI Insight · Sep 21, 2026Peer-reviewedMolecular Biology